Kyle J. Bednar
1Patents
0h-index
4Co-inventors
19Inventor score
Filing activity: Mar 23, 2022 → Mar 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12180278B2 | Antibody targeting CD22 and CD79B | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.